Kinnate Biopharma
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. The net income raised on -$112,649,000 over the previous period. Total operating expenses were $118,209,000.
Profit Margin
| 2018 | 0 | -7.63M | |
|---|---|---|---|
| 2019 | 0 | -11.92M | |
| 2020 | 0 | -35.43M | |
| 2021 | 0 | -89.41M | |
| 2022 | 0 | -114.02M | |
| 2023 | 0 | -112.64M |
KNTE Income Statement (2018 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|
Revenue | ||||||
Revenue | 0 | 0 | 0 | 0 | 0 | 0 |
Cost of revenue | 799K | 604K | 123K | 83K | 0 | 0 |
Gross profit | -799K | -604K | -123K | -83K | 0 | 0 |
Operating exp. | ||||||
Research and development | 90.76M | 88.15M | 67.16M | 29.23M | 8.95M | 5.67M |
Selling and marketing | 0 | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 118.20M | 118.52M | 90.11M | 36.00M | 12.01M | 7.63M |
Operating income | -119.00M | -118.52M | -90.11M | -36.00M | -12.01M | -7.63M |
Other income (expenses), net | 6.35M | 2.25M | 348K | 240K | 43K | 0 |
Income before tax | -112.64M | -116.27M | -89.76M | -35.76M | -11.96M | -7.63M |
Income tax expense | 0 | -2.25M | -348K | -328K | -43K | 0 |
Net income | -112.64M | -114.02M | -89.41M | -35.43M | -11.92M | -7.63M |
Earnings per share | ||||||
Basic EPS | -2.42 | -2.59 | -2.05 | -0.81 | -0.28 | -0.71 |
Diluted EPS | -2.42 | -2.59 | -2.05 | -0.81 | -0.28 | -0.71 |
| Data source | Data source | Data source |